Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
'Miracle' drug innovation could see a new Wegovy launch every couple of years, Larry Summer says
Tags World economy Pharmaceuticals World Economy
From CNBC.com News
GLP-1s and Brian Thompson’s killing loom large at top health-care conference
Tags Waystar Holding Corp Hospitals Amazon/com Inc
From CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
Tags Social issues Breaking News: Business Amgen Inc
From CNBC.com News
Eli Lilly CEO expects new weight loss pill to be approved next year
Tags Breaking News: Business Health care industry Business News
From CNBC.com News
High-cost weight loss drugs are sending employers to nutrition counseling in a boost for startups
Tags Labor economy Health care industry Pharmaceuticals
From CNBC.com News
Medicare can now cover Eli Lilly’s Zepbound for sleep apnea, CMS says
Tags Companies Business News Health & Science
From CNBC.com News
Cramer's Lightning Round: 'I'd be careful' with Novo Nordisk
Tags Investment Strategy stocks Business News
From CNBC.com News
Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdown
Tags Progyny Inc AI / Artificial Intelligence Tempus AI Inc
From CNBC.com News
FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Health care costs
From CNBC.com News
CNBC Daily Open: With cooler-than-expected PCE, would the Fed’s dot plot have looked different?
Tags Market Outlook Asia Markets Intel Corp
From CNBC.com News
FDA approves Eli Lilly's weight loss drug Zepbound for sleep apnea, expanding use in U.S.
Tags Science Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Novo Nordisk shares plunge 22% after CagriSema obesity drug trial results
Tags Biotechnology Breaking News: Europe Pharmaceuticals
From CNBC.com News
Merck to develop weight loss pill from Chinese drugmaker in up to $2 billion licensing deal
Tags Pharmaceuticals Business News Health & Science
From CNBC.com News
Europe's economy faces a bumpy ride in 2025. Here are 5 things to watch
Tags Stock markets Prices Europe Economy
From CNBC.com News
Healthy Returns: Novo Nordisk's Ozempic faces scrutiny over potential link to rare eye condition
Tags Social issues Health care industry Healthy Returns
From CNBC.com News
Healthy Returns: A huge deal to boost Novo Nordisk's manufacturing is one step closer to closing
Tags LILLY DRN Health & Science Healthy Returns
From CNBC.com News
Ro to offer lower-price vials of weight loss drug Zepbound by teaming up with Eli Lilly
Tags Business Amazon/com Inc Novo Nordisk A/S
From CNBC.com News
The weight-loss drug boom has become one of the internet's biggest scams
Tags Cybersecurity Novo Nordisk A/S Technology
From CNBC.com News
Healthy Returns: Wall Street mulls over Amgen’s weight loss drug data
Tags AstraZeneca PLC Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
Tags Business Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Hiccups in ETFs tracking MicroStrategy occurring as bull market fuels trading boom in single-stock funds
Tags Wall Street NVIDIA Corp Markets
From CNBC.com News
Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial
Tags Business Science Novo Nordisk A/S
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Abercrombie & Fitch Co Business News Earnings
From CNBC.com News
Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
Tags Amgen Inc Health care industry Biotechnology
From CNBC.com News
Amgen stock falls as analysts mull over weight loss drug’s bone density data
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Business
From CNBC.com News
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
Tags AstraZeneca PLC Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
Healthy Returns: Wegovy may reduce knee pain in patients with a type of arthritis and obesity
Tags Healthy Returns Health & Science UnitedHealth Group Inc
From CNBC.com News
Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
Tags Companies Business News LILLY DRN
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
Tags Biotech and Pharmaceuticals Science Novo Nordisk A/S
From CNBC.com News
Ozempic And Wegovy Maker Novo Nordisk Asks FDA To Halt Production Of Compounded Fat Loss Drugs Due To Their 'Inherent Complexity'
Tickers HIMS LLY NEWS NVO
Tags wegovy Food and Drug Administration Ozempic
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.